Drug discount agreement according to § 130c para. 1 SGB V for the fixed-dose combination drug Glecaprevir and Pibrentasvir
About This Opportunity
TranslatedThis tender concerns an agreement according to § 130c Paragraph 1 of the German Social Code Book V (SGB V). The agreement pertains to the granting of rebates for patented medicinal products featuring the fixed-combination active ingredients Glecaprevir and Pibrentasvir, marketed under the brand name Maviret®. The objective is to negotiate pricing and rebate conditions for this specific pharmaceutical product within the German healthcare system, ensuring cost-effectiveness while maintaining patient access to necessary treatments. This is a regulatory process involving pharmaceutical manufacturers and health insurance providers.
This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals and Health Financing. Located in Germany, Europe, this opportunity is open to firms and consortiums.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Auto-translated from GermanAgreement according to § 130c para. 1 SGB V on granting discounts for patented medicines with the fixed-dose combination drug Glecaprevir and Pibrentasvir (Maviret®)
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 30, 2026. Last refreshed 37 days ago. Original language: German. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About AOK Baden-Württemberg
AOK Baden-Württemberg has issued 32 procurement notices on BidsFactory, including 4 currently open and 19 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Germany. Notices are distributed via TED - Tenders Electronic Daily (EU), DÖE Bekanntmachungsservice (Germany), and service.bund.de (Germany). Most recent publication: September 7, 2026.
Frequently asked questions about this tender
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
AbbVie Deutschland GmbH & Co. KG was awarded the contract for €216,000. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Germany. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to AbbVie Deutschland GmbH & Co. KG. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by AOK Baden-Württemberg in Germany. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.